查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403435

到 2030 年的遠距藥事照護市場預測：按服務、交付模式、設備、最終用戶和地區進行的全球分析

Telepharmacy Market Forecasts to 2030 - Global Analysis By Service (Drug Therapy Monitoring, Patient Counselling and Other Services), By Delivery Mode (On-premises, Cloud-based and Web-based), Device, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球遠距藥事照護市場規模將達92億美元，預計2030年將達到301億美元，預測期內複合年成長率為18.4%。

遠距藥事照護包括透過通訊和數位平台提供的遠端藥房服務。使藥劑師能夠遠端諮詢、管理治療和分發藥物。遠距藥事照護增加了藥局服務的可及性，特別是在服務不足的地區，促進藥物醫囑遵從性，並提供虛擬諮詢，透過遠端互動和技術解決方案提供患者護理和藥物支援。我們將為您提供支援。

根據美國國立衛生研究院 (NIH) 的一項調查，約 77% 的受訪者回答說，在 COVID-19 大流行期間，患者對親自去藥房和遠距藥物治療的態度和偏好預約治療。

對遠距醫療解決方案的需求不斷成長

對遠距醫療解決方案不斷成長的需求正在推動遠距藥局市場的發展。地理障礙、藥局管道有限以及對便利醫療保健選擇的需求等因素正在推動這一需求，特別是在農村和服務不足的地區。遠距藥理學透過提供藥物諮詢、治療管理和處方箋補充等遠距藥物服務來應對這些挑戰。人們對虛擬互動的日益偏好，加上對方便、及時的醫療保健的偏好，使遠距藥事照護成為關鍵的解決方案，推動其普及和市場成長。

不同司法管轄區的許可挑戰

法規和許可要求因地區和州而異，需要複雜的合規程序。跨多個司法管轄區運作的遠距藥物治療服務通常必須遵循不同的法律體制，並具有嚴格且耗時的許可流程。遵守不同法規的需要使業務變得複雜，增加了管理負擔，並阻礙了市場的快速擴張。跨司法管轄區應對不同許可要求的這項挑戰阻礙了遠距藥物治療服務的無縫交付，並限制了地理覆蓋範圍和擴充性。

對遠距藥物治療的認知不斷增強

人們對遠距醫療治療的認知不斷增強，為市場提供了巨大的機會。隨著遠距醫療保健解決方案在患者和醫療保健提供者中的擴展，我們將繼續探索遠距藥局提供的好處，特別是在服務不足的地區，改善獲得藥品服務的機會，加強藥物管理，並提高護理覆蓋率。人們越來越意識到以下問題：擴張。這種認可將推動遠距醫療解決方案的接受和採用，並鼓勵患者和醫療保健提供者接受遠距服務，從而推動市場成長並鼓勵更廣泛地實施舉措。

隱私和資料安全風險

遠端處理敏感的患者資訊會增加遭受網路威脅、資料外洩和詐欺存取的脆弱性。保護患者機密並遵守嚴格的隱私法規至關重要。醫療資料處理不當或詐欺的披露可能會損害患者的信任並導致法律後果，進一步阻礙市場擴張。

COVID-19 的影響：

COVID-19大流行顯著加速了遠距藥物治療解決方案的採用。這場危機凸顯了對遠距醫療保健存取的需求，並促使人們越來越依賴遠端醫療和遠距藥房服務。鎖門、社交距離措施和對醫療機構的限制導致患者和提供者透過遠距藥房平台接受遠端諮詢、處方箋補充和藥物管理。需求的激增證明了遠距醫療治療在確保護理連續性方面的潛力，並塑造了向遠距藥物服務的長期轉變。

預計患者諮詢產業在預測期內將是最大的

患者諮詢領域預計將主導遠距藥事照護市場，因為它在藥物管理和以患者為中心的護理中發揮關鍵作用。遠距藥物治療為患者提供全面的用藥指導、用藥說明、副作用管理，並促進個人化諮詢。醫療保健越來越關注患者的參與和藥物醫囑遵從性，這使得遠距藥事照護提供遠距諮詢服務的能力對於慢性病和複雜的治療尤為重要。這種對客製化諮詢的需求推動了患者諮詢領域的發展，並凸顯了透過遠距藥事照護服務確保有效的藥物護理的重要性。

預計醫院業在預測期內複合年成長率最高。

由於不斷變化的醫療保健動態，預計醫院部門的遠距藥事照護市場將顯著成長。醫院擴大採用遠距醫療治療來最佳化患者護理、簡化藥物管理並擴展遠端位置的服務。將遠距醫療解決方案整合到醫院系統中可以提高藥物醫囑遵從性並促進虛擬諮詢，特別是對於出院患者和慢性病患者。此外，隨著遠距藥理學增強醫療保健的可及性、降低再入院率並確保持續的藥物支持，醫院部門將大大擴展。

比最大的地區

由於先進的醫療基礎設施、技術主導的創新和成熟的遠端醫療環境，北美預計將在遠距醫療治療市場中佔據最大的市場佔有率。該地區擁有強大的法規結構，支持遠距醫療的採用。此外，醫療保健支出的增加、人口高齡化以及醫療保健服務的改善正在推動對遠距醫療服務的需求。憑藉成熟的遠端醫療實踐和廣泛的數位連接，北美有望利用技術力和醫療保健進步來滿足不斷變化的患者需求，從而在遠距醫療治療領域處於領先地位。

複合年成長率最高的地區：

由於醫療基礎設施的擴大、數位技術的日益採用以及對無障礙醫療服務的需求不斷成長，預計亞太地區遠距醫療市場將顯著成長。遠程藥理學透過提供便捷的製藥專業知識來解決地理障礙，特別是在偏遠地區。此外，該地區精通技術的人口以及對高效醫療保健服務系統不斷成長的需求進一步推動了遠距藥局解決方案的採用，使亞太地區的遠距藥局服務實現了良好的成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球遠距藥事照護市場：依服務分類

  • 藥物治療監測
  • 病人諮詢
  • 處方藥補充核准
  • 遠程配藥
  • 其他服務

第6章全球遠距藥事照護市場：依交付方式分類

  • 本地
  • 雲端基礎
  • 基於網路的

第7章全球遠距藥事照護市場：依設備分類

  • 電腦
  • 智慧型手機
  • 平板電腦和資訊亭

第8章全球遠距藥事照護市場：依最終用戶分類

  • 初級保健中心
  • 醫院
  • 其他最終用戶

第9章全球遠距藥事照護市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Capsule Technologies
  • CPS Solutions, LLC
  • Digital Pharmacist Inc.
  • McKesson Ventures
  • Medication Review, Inc.
  • Medtel Communications
  • Omnicell, Inc.
  • PharmaPoint
  • PioneerRx
  • Pipeline Healthcare
  • TelePharm (Cardinal Health)
  • Transaction Data Systems, Inc.
  • ZipDrug
Product Code: SMRC24660

According to Stratistics MRC, the Global Telepharmacy Market is accounted for $9.2 billion in 2023 and is expected to reach $30.1 billion by 2030 growing at a CAGR of 18.4% during the forecast period. Telepharmacy encompasses remote pharmaceutical services delivered via telecommunications and digital platforms. It enables pharmacists to provide medication consultations, therapy management and dispensing remotely. Telepharmacy enhances accessibility to pharmacy services, especially in underserved regions, facilitates medication adherence, and offers virtual consultations, aiding in patient care and medication support through remote interactions and technological solutions.

According to the National Institute of Health (NIH) survey on patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy during the COVID-19 pandemic, about 77% of respondents preferred appointments via telepharmacy.

Market Dynamics:

Driver:

Growing demand for remote healthcare solutions

The increasing demand for remote healthcare solutions drives the telepharmacy market. Factors such as geographic barriers, limited access to pharmacies and the need for convenient healthcare options, especially in rural or underserved areas, fuel this demand. Telepharmacy addresses these challenges by offering remote pharmaceutical services, including medication consultations, therapy management, and prescription refills. The growing preference for virtual interactions, coupled with the desire for accessible and timely healthcare, positions telepharmacy as a pivotal solution, propelling its adoption and market growth.

Restraint:

Challenges in obtaining licenses across different jurisdictions

Different regulations and licensing requirements in different regions or states demand complex compliance procedures. Telepharmacy services operating across multiple jurisdictions must navigate varied legal frameworks, which often involve rigorous and time-consuming processes for licensure. The need for adherence to distinct regulations complicates operations, increases administrative burdens, and hampers swift market expansion. This challenge of navigating diverse licensing requirements across jurisdictions impedes the seamless delivery of telepharmacy services, limiting geographic reach and scalability.

Opportunity:

Growing awareness regarding the telepharmacy

The increasing awareness surrounding telepharmacy presents a significant opportunity in the market. As remote healthcare solutions grow among patients and healthcare providers, there's heightened recognition of the benefits telepharmacy offers, including improved accessibility to pharmaceutical services, enhanced medication management and expanded healthcare reach, especially in underserved areas. This awareness fosters greater acceptance and adoption of telepharmacy solutions, encouraging both patients and healthcare organizations to embrace these remote services, thereby driving the market's growth and facilitating a more widespread implementation of telepharmacy initiatives.

Threat:

Privacy and data security risks

Handling sensitive patient information remotely increases vulnerability to cyber threats, data breaches and unauthorized access. Protecting patient confidentiality and complying with stringent privacy regulations have become paramount. Mishandling or unauthorized disclosure of health data erodes patient trust and could lead to legal repercussions, which further hinders market expansion.

COVID-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of telepharmacy solutions. The crisis highlighted the need for remote healthcare access, prompting increased reliance on telemedicine and telepharmacy services. Lockdowns, social distancing measures and healthcare facility limitations pushed patients and providers to embrace remote consultations, prescription refills and medication management through telepharmacy platforms. This surge in demand showcased telepharmacy's potential in ensuring continuity of care, shaping a long-term shift towards remote pharmaceutical services.

The patient counselling segment is expected to be the largest during the forecast period

The patient counselling segment is expected to dominate the telepharmacy market due to its pivotal role in medication management and patient-centric care. Telepharmacy facilitates personalized counseling, empowering patients with comprehensive medication guidance, dosage instructions, and adverse effects management. As healthcare increasingly focuses on patient engagement and adherence, telepharmacy's ability to offer remote counseling services, especially for chronic conditions or complex therapies, becomes crucial. This demand for tailored counseling propels the patient counselling segment, emphasizing its significance in ensuring effective pharmaceutical care through telepharmacy services.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to experience substantial growth in the telepharmacy market due to evolving healthcare dynamics. Hospitals increasingly adopt telepharmacy to optimize patient care, streamline medication management, and extend services remotely. The integration of telepharmacy solutions within hospital systems enhances medication adherence and facilitates virtual consultations, especially for discharged patients or those with chronic conditions. Additionally, telepharmacy augments healthcare access, reducing readmission rates and ensuring continuous medication support, positioning the hospitals segment for significant expansion.

Region with largest share:

North America is expected to register the largest market share in the telepharmacy market, owing to its advanced healthcare infrastructure, tech-driven innovation, and mature telehealth landscape. The region boasts robust regulatory frameworks supporting telepharmacy adoption. Furthermore, increased healthcare spending, a growing aging population, and the emphasis on improving healthcare access drive the demand for remote pharmaceutical services. With established telehealth practices and widespread digital connectivity, North America is primed to lead in telepharmacy, leveraging its technological prowess and healthcare advancements to cater to evolving patient needs.

Region with highest CAGR:

Asia Pacific is set to witness substantial growth in the telepharmacy market due to the region's expanding healthcare infrastructure, increasing adoption of digital technology and rising demand for accessible healthcare services. Telepharmacy addresses geographical barriers, especially in remote areas, by offering convenient access to pharmaceutical expertise. Moreover, the region's tech-savvy population and the escalating need for efficient healthcare delivery systems further propel the adoption of telepharmacy solutions, positioning Asia Pacific for lucrative growth in remote pharmaceutical services.

Key players in the market:

Some of the key players in telepharmacy market include Capsule Technologies, CPS Solutions, LLC, Digital Pharmacist Inc., McKesson Ventures, Medication Review, Inc., Medtel Communications, Omnicell, Inc., PharmaPoint, PioneerRx, Pipeline Healthcare, TelePharm (Cardinal Health), Transaction Data Systems, Inc. and ZipDrug.

Key Developments:

In May 2023, OneroRx is pleased to announce that Community Pharmacy of Dunlap is open to serve residents of Dunlap, Iowa, and its surrounding communities. Community Pharmacy has worked closely with Dunlap Community Development Corporation (DCDC) to bring pharmacy services back to the area.

In July 2022, RxLive, a provider of population health pharmacy solutions, today announced a $5 million Series A funding round. The digital health startup's round was led by SpringTide, a healthtech-focused venture capital firm, with participation by Cardinal Health™, a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions in health care. RxLive has raised a total of $8 million to date.

Services Covered:

  • Drug Therapy Monitoring
  • Patient Counselling
  • Refill Authorization for Prescription Drugs
  • Remote Dispensing
  • Other Services

Delivery Modes Covered:

  • On-premises
  • Cloud-based
  • Web-based

Devices Covered:

  • Computers
  • Smartphones
  • Tablets and Kiosk

End Users Covered:

  • Primary Care Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Telepharmacy Market, By Service

  • 5.1 Introduction
  • 5.2 Drug Therapy Monitoring
  • 5.3 Patient Counselling
  • 5.4 Refill Authorization for Prescription Drugs
  • 5.5 Remote Dispensing
  • 5.6 Other Services

6 Global Telepharmacy Market, By Delivery Mode

  • 6.1 Introduction
  • 6.2 On-premises
  • 6.3 Cloud-based
  • 6.4 Web-based

7 Global Telepharmacy Market, By Device

  • 7.1 Introduction
  • 7.2 Computers
  • 7.3 Smartphones
  • 7.4 Tablets and Kiosk

8 Global Telepharmacy Market, By End User

  • 8.1 Introduction
  • 8.2 Primary Care Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Telepharmacy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

11.1 Capsule Technologies

11.2 CPS Solutions, LLC

11.3 Digital Pharmacist Inc.

11.4 McKesson Ventures

11.5 Medication Review, Inc.

11.6 Medtel Communications

11.7 Omnicell, Inc.

11.8 PharmaPoint

11.9 PioneerRx

11.10 Pipeline Healthcare

11.11 TelePharm (Cardinal Health)

11.12 Transaction Data Systems, Inc.

11.13 ZipDrug

List of Tables

  • Table 1 Global Telepharmacy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
  • Table 3 Global Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
  • Table 4 Global Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
  • Table 5 Global Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
  • Table 6 Global Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
  • Table 7 Global Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 8 Global Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 9 Global Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
  • Table 10 Global Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
  • Table 11 Global Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
  • Table 12 Global Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
  • Table 13 Global Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
  • Table 14 Global Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
  • Table 15 Global Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
  • Table 16 Global Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
  • Table 18 Global Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 19 Global Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 20 North America Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
  • Table 22 North America Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
  • Table 23 North America Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
  • Table 24 North America Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
  • Table 25 North America Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
  • Table 26 North America Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 27 North America Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 28 North America Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
  • Table 29 North America Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
  • Table 30 North America Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
  • Table 31 North America Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
  • Table 32 North America Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
  • Table 33 North America Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
  • Table 34 North America Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
  • Table 35 North America Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 North America Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
  • Table 37 North America Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 38 North America Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 39 Europe Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
  • Table 41 Europe Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
  • Table 42 Europe Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
  • Table 43 Europe Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
  • Table 44 Europe Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
  • Table 45 Europe Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 46 Europe Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 47 Europe Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
  • Table 48 Europe Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
  • Table 49 Europe Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
  • Table 50 Europe Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
  • Table 51 Europe Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
  • Table 52 Europe Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
  • Table 53 Europe Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
  • Table 54 Europe Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 55 Europe Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
  • Table 56 Europe Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 57 Europe Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 58 Asia Pacific Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
  • Table 60 Asia Pacific Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
  • Table 61 Asia Pacific Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
  • Table 62 Asia Pacific Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
  • Table 63 Asia Pacific Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
  • Table 64 Asia Pacific Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 65 Asia Pacific Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 66 Asia Pacific Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
  • Table 67 Asia Pacific Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
  • Table 68 Asia Pacific Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
  • Table 69 Asia Pacific Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
  • Table 70 Asia Pacific Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
  • Table 71 Asia Pacific Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
  • Table 72 Asia Pacific Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
  • Table 73 Asia Pacific Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 Asia Pacific Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
  • Table 75 Asia Pacific Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 76 Asia Pacific Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 77 South America Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
  • Table 79 South America Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
  • Table 80 South America Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
  • Table 81 South America Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
  • Table 82 South America Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
  • Table 83 South America Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 84 South America Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 85 South America Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
  • Table 86 South America Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
  • Table 87 South America Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
  • Table 88 South America Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
  • Table 89 South America Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
  • Table 90 South America Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
  • Table 91 South America Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
  • Table 92 South America Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 South America Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
  • Table 94 South America Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 95 South America Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 96 Middle East & Africa Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
  • Table 98 Middle East & Africa Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
  • Table 99 Middle East & Africa Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
  • Table 100 Middle East & Africa Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
  • Table 101 Middle East & Africa Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
  • Table 102 Middle East & Africa Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 103 Middle East & Africa Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 104 Middle East & Africa Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
  • Table 105 Middle East & Africa Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
  • Table 106 Middle East & Africa Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
  • Table 107 Middle East & Africa Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
  • Table 108 Middle East & Africa Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
  • Table 109 Middle East & Africa Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
  • Table 110 Middle East & Africa Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
  • Table 111 Middle East & Africa Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 112 Middle East & Africa Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
  • Table 113 Middle East & Africa Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 114 Middle East & Africa Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)